{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Neurotransmitter disorders",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_levodopa",
          "name": "Levodopa"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_dopamine",
          "name": "Dopamine"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_selegiline",
          "name": "Selegiline"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_rasagiline",
          "name": "Rasagiline"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_amantadine",
          "name": "Amantadine"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_pramipexole",
          "name": "Pramipexole"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_ropinirole",
          "name": "Ropinirole"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_bromocriptine",
          "name": "Bromocriptine"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_entacapone",
          "name": "Entacapone"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_cabergoline",
          "name": "Cabergoline"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_fluoxetine",
          "name": "Fluoxetine"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_venlafaxine",
          "name": "Venlafaxine"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 2
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_levodopa",
          "type": "Drug",
          "label": "Levodopa",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dopamine",
          "type": "Drug",
          "label": "Dopamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_selegiline",
          "type": "Drug",
          "label": "Selegiline",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rasagiline",
          "type": "Drug",
          "label": "Rasagiline",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_amantadine",
          "type": "Drug",
          "label": "Amantadine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_pramipexole",
          "type": "Drug",
          "label": "Pramipexole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ropinirole",
          "type": "Drug",
          "label": "Ropinirole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_bromocriptine",
          "type": "Drug",
          "label": "Bromocriptine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_entacapone",
          "type": "Drug",
          "label": "Entacapone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cabergoline",
          "type": "Drug",
          "label": "Cabergoline",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fluoxetine",
          "type": "Drug",
          "label": "Fluoxetine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_venlafaxine",
          "type": "Drug",
          "label": "Venlafaxine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target_dopamine_receptor",
          "type": "Target",
          "label": "Dopamine Receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_dopaminergic_pathway",
          "type": "Pathway",
          "label": "Dopaminergic Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease_neurotransmitter_disorder",
          "type": "Disease",
          "label": "Neurotransmitter Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_phenotype_x",
          "type": "Phenotype",
          "label": "Phenotype X",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_phenotype_y",
          "type": "Phenotype",
          "label": "Phenotype Y",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_levodopa",
          "target": "n_target_dopamine_receptor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "作用于多巴胺受体，治疗神经递质失调相关症状"
        },
        {
          "source": "drug_dopamine",
          "target": "n_target_dopamine_receptor",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接用于补充多巴胺，对神经递质失调有直接影响"
        },
        {
          "source": "drug_selegiline",
          "target": "n_target_dopamine_receptor",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "抑制单胺氧化酶，增强多巴胺的效力"
        },
        {
          "source": "drug_rasagiline",
          "target": "n_target_dopamine_receptor",
          "relation": "inhibits",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "类似于Selegiline，增加神经传递促进效应"
        },
        {
          "source": "drug_amantadine",
          "target": "n_target_dopamine_receptor",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "提高多巴胺的传递及释放"
        },
        {
          "source": "drug_pramipexole",
          "target": "n_target_dopamine_receptor",
          "relation": "activates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "选择性激动多巴胺受体，主要用于帕金森病治疗"
        },
        {
          "source": "drug_ropinirole",
          "target": "n_target_dopamine_receptor",
          "relation": "activates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "类似机制，用于帕金森病相关治疗"
        },
        {
          "source": "drug_bromocriptine",
          "target": "n_target_dopamine_receptor",
          "relation": "activates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "dopamine agonists对治疗有明确效用"
        },
        {
          "source": "n_target_dopamine_receptor",
          "target": "n_pathway_dopaminergic_pathway",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "多巴胺受体是多巴胺通路的重要组成部分"
        },
        {
          "source": "n_pathway_dopaminergic_pathway",
          "target": "n_disease_neurotransmitter_disorder",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "多巴胺通路异常导致神经递质失调"
        },
        {
          "source": "n_target_dopamine_receptor",
          "target": "n_ph_phenotype_x",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "影响神经递质功能的药物直接关联症状表现"
        },
        {
          "source": "n_target_dopamine_receptor",
          "target": "n_ph_phenotype_y",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "调节多巴胺的药物会影响多种表型特征"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "通过对多巴胺受体的作用影响神经递质失调的相关表型",
        "confidence": "high"
      },
      {
        "id": "C2",
        "text": "多种药物通过激动或调节多巴胺系统治疗神经递质失调",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "假设所述药物能有效到达靶器官并产生药理效果"
    ],
    "uncertainties": [
      "不同药物与靶点的特异性仍需进一步的实验证实"
    ],
    "next_focus_for_pi": [
      "考量是否需补充额外的药物与路径以增强支持链"
    ]
  }
}